News | July 09, 2025
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
The submission is based on data from the STEP UP and STEP UP T2D clinical trials
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
These medicines are essential in preventing RhD immunisation during pregnancy
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
Approval based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death for the Imfinzi regimen vs. neoadjuvant chemotherapy alone
The iStent platform uses tiny surgical implants to lower eye pressure by restoring the eye’s natural fluid drainage system in patients with glaucoma
Review will evaluate effectiveness in treating alcohol withdrawal syndrome and supporting abstinence, as well as measures to mitigate risk of abuse
Subscribe To Our Newsletter & Stay Updated
